- DKK36.31bn
- DKK45.28bn
- DKK24.63bn
Europe Research Roundup: BMW, Fugro, Mercedes-Benz
Europe Research Roundup: Aena, Geberit, Hays
Europe Research Roundup: Adidas, AXA, Greencore
Brief: H. Lundbeck Announces Positive Results From RESOLUTION Trial
Europe Research Roundup: Covivio, Mercedes-Benz Group, Persimmon
Brief: Lundbeck Announces Expiration Of Longboard Tender Offer
Danish drugmaker H Lundbeck rises on Q3 results beat, annual view upgrade
Brief: H Lundbeck Expects 2024 Adjusted EBITDA Growth To Be 17% To 20% At CER
Brief: Lundbeck Q3 Revenue DKK 5,722 Million
Brief: Lundbeck Announces Positive Results From Phase III Pivotal Trial (Sunrise) Of Vyepti In Migraine Prevention
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Lundbeck To Acquire Longboard Pharmaceuticals
Longboard Pharma jumps on $2.6 bln Lundbeck buyout deal
Denmark's Lundbeck to buy Longboard Pharma in $2.6 billion deal (updated)
Lundbeck to buy Longboard Pharma in $2.6 billion deal
Brief: Lundbeck And Iambic Therapeutics In Strategic Partnership To Leverage AI For Drug Discovery
Europe Research Roundup: Argenx, Glencore, Volvo Car